Jul 2, 2020
Erik Messamore, M.D., Ph.D., joins Dr. Dixon and Dr. Berezin to discuss suggestions for informing the public more effectively about the potential benefits and risks of marijuana in state medical marijuana programs.
Dr. Messamore is Associate Professor of Psychiatry at Northeast Ohio Medical University and Medical Director of the university's Best Practices in Schizophrenia Treatment Center.
- How Dr. Messamore became interested in medical marijuana policy [2:33]
- Points raised by patients regarding the benefits and risks of medical marijuana [5:57]
- A history of the legalization of medical marijuana in the United States [7:54]
- The difference between the authorization of marijuana for medical use relative to recreational use [10:24]
- Discrepancies between the approval processes of regular medicines and medical marijuana [12:32]
- The role of industry and lobbying [18:09]
- Recommendations for what state governments should be doing [19:22]
- Side effects of cannabis [20:43]
- Arguments for the continued loosening of cannabis policies [24:40]
- Response to cannabis advocates [27:28]
Subscribe to the podcast here.
Check out Editor's Choice, a set of curated collections from the rich resource of articles published in the journal. Sign up to receive notification of new Editor's Choice collections.
Browse other articles on our web site.
Be sure to let your colleagues know about the podcast, and please rate and review it wherever you listen to it.
Listen to other podcasts produced by the American Psychiatric Association.
Follow the journal on Twitter.
E-mail us at psjournal@psych.org
This article is part of the Think Bigger, Do Good series commissioned by the Thomas Scattergood Behavioral Health Foundation, Peg's Foundation, the Patrick P. Lee Foundation, and the Peter & Elizabeth Tower Foundation. The full series can be viewed at www.ThinkBiggerDoGood.org.